ChemoCentryx, Inc.·4

Jan 3, 7:24 PM ET

SINGH RAJINDER 4

4 · ChemoCentryx, Inc. · Filed Jan 3, 2018

Insider Transaction Report

Form 4
Period: 2018-01-01
SINGH RAJINDER
SVP, Research
Transactions
  • Exercise/Conversion

    Common Stock

    2018-01-01+10,00010,000 total
  • Tax Payment

    Common Stock

    2018-01-01$5.95/sh5,670$33,7374,330 total
  • Exercise/Conversion

    Restricted Stock Units

    2018-01-0110,00020,000 total
    Common Stock (10,000 underlying)
Footnotes (4)
  • [F1]Shares were acquired upon vesting of restricted stock units awarded on February 28, 2017.
  • [F2]Represents shares withheld upon vesting of restricted stock units to satisfy tax withholding obligation.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
  • [F4]The restricted stock units awarded on February 28, 2017, vest in three equal installments on January 1, 2018, January 1, 2019, and January 1, 2020, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION